Goldman Sachs enters the final stretch before its October 13 Q3 earnings with the stock trading nearly 16% below consensus price targets — and the Street just moved those targets in opposite directions.
The most notable development this week came from Citigroup, where analyst Benjamin Gerlinger cut his price target sharply, from $1,200 to $1,050, while holding a Neutral rating. The cut lands against a backdrop of ongoing price weakness: GS closed at $949.49 on Tuesday, down 2.8% on the week and 8.6% over the past month. That gap between the current price and the consensus mean target of $1,134 is wide enough to catch attention, but the Citi move pulls in the other direction — a sign that at least one firm sees the stock's recent retreat as fair rather than overdone. Further back in July, following Q2 results that sent the stock up 10% in a single session, a wave of targets were lifted across Barclays, BofA, Evercore, and BMO. The post-print enthusiasm has since given way to more measured positioning, with BofA the clearest bull at $1,300 and Evercore ISI maintaining Outperform with a $1,210 target. JPMorgan, by contrast, held Neutral at a comparatively cautious $955 — a figure the stock has now traded through to the downside.
The bull and bear cases are well-defined heading into October. Bulls point to Goldman's deepening wealth and asset management franchise, its consistent returns on equity, and its record of beating estimates — the firm ranks near the 89th percentile on EPS surprise across the coverage universe. Bears focus on the firm's continued dependence on capital markets revenue, where an economic slowdown or rate reversal could bite hard. The 30-day forward earnings momentum score of 33 — below the mid-point — suggests analyst estimate revisions have not been running in GS's favour recently, even if the 90-day momentum picture (91st percentile) is far more constructive. The price-to-book multiple has compressed about 9% over 30 days to 2.39x, the clearest valuation signal of the recent slide.
The sector pullback remains the dominant context. As flagged in the previous note from September 16, the sell-off has been indiscriminate. This week, Morgan Stanley fell 3.0%, BNY dropped 2.9%, and Evercore slipped 2.8%. GS's 2.8% weekly loss puts it squarely in the middle of the pack. One notable outlier: Interactive Brokers gained 3.5% on the week, suggesting the weakness is specific to advisory and capital-markets-exposed names rather than financials broadly.
Short positioning tells a quiet story by comparison. Short interest is 2.2% of the free float — unchanged in character from the prior note, though up roughly 12% over 30 days in share terms. That monthly drift is worth noting, but the absolute level remains low. Borrow costs have eased 15% over the week to 0.31%, and availability is effectively unlimited — over 162 million shares available to borrow against a short position of around 7 million. Options positioning has turned notably less defensive than usual: the put/call ratio is at 0.81, running 1.5 standard deviations below its 20-day average of 0.86. That is close to the 52-week low of 0.80. Call activity is dominating the options tape, which sits in tension with the stock's price slide — either options traders are buying dips, or they see the Q3 print as a positive catalyst.
The earnings history is relevant here. The last Q3 print — July 14 — sent GS up 10.2% in a single day and held most of that gain over the following week. The April 29 Q1 results were a non-event by comparison, a near-flat day. With the Q3 date confirmed for October 13, the question heading into next week is whether the call-heavy options posture reflects genuine conviction on the print, or simply relative cheapness in upside hedges after a month of price weakness.
See the live data behind this article on ORTEX.
Open GS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
